9 August 2022 - Today, the U.S. FDA  issued an emergency use authorisation for the Jynneos vaccine to allow health care providers to use the vaccine by intradermal injection for individuals 18 years of age and older who are determined to be at high risk for monkeypox infection. 

This will increase the total number of doses available for use by up to five fold.

Read FDA press release